A detailed history of Tyler Stone Wealth Management transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Tyler Stone Wealth Management holds 42,016 shares of ANIX stock, worth $94,536. This represents 0.03% of its overall portfolio holdings.

Number of Shares
42,016
Previous 21,008 100.0%
Holding current value
$94,536
Previous $46,000 186.96%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$2.21 - $3.48 $46,427 - $73,107
21,008 Added 100.0%
42,016 $132,000
Q4 2021

Feb 22, 2022

BUY
$2.88 - $5.5 $60,503 - $115,544
21,008 New
21,008 $62,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $69M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Tyler Stone Wealth Management Portfolio

Follow Tyler Stone Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tyler Stone Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Tyler Stone Wealth Management with notifications on news.